The global radiopharmaceutical market is a large and rapidly growing industry, driven by advancements in radiodiagnostics, radiotherapeutics and population demand. The advances in radiodiagnostics is helping detect diseases like cancer in early stages as well as locations and quantitation in case of metastasis. Targeted radiotherapies is and emerging field and treatments for new indications are are being developed with lesser toxicity to adjacent and normal tissue. These advances are fueling substantial growth in this industry.
Diagnostic radiopharmaceuticals have a dominent share of the current market but therapeutic radiopharmaceuticals are expected to catch up and dominate the market share in the coming years. A research report for the estimation of 2024 global radiopharmaceuticals market is ready for purchase in the Services section.
